Freeline Therapeutics IPO

Freeline is a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of patients suffering from inherited systemic debilitating diseases.

Register for Details

For more details on financing and valuation for Freeline Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Freeline Therapeutics

Forge green plus iconForge green minus icon

What is Freeline Therapeutics's IPO price?

Freeline Therapeutics's IPO price is $6.37 as of 1/18/24.
Forge green plus iconForge green minus icon

What is Freeline Therapeutics's IPO price?

The IPO price for Freeline Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Freeline Therapeutics pre-IPO?

Freeline Therapeutics is privately held company and is not publicly traded, therefor investing in Freeline Therapeutics pre-IPO is only available to accredited investors. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to invest in private companies before their potential IPO. If you are not an accredited investor, discover how to begin the the process to potentially qualify for new investment opportunities.

Forge green plus iconForge green minus icon

What is the value of my Freeline Therapeutics shares?

To determine the value of your Freeline Therapeutics shares, create a free account to gain access to Forge’s platform. Forge Markets contains pricing information for hundreds of pre-IPO companies. A Private Market Specialist will also be available to assist you with any inquiries related to your Freeline Therapeutics shares. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Can you sell Freeline Therapeutics before it goes public?

Yes, you can seek to sell shares in Freeline Therapeutics while it remains private. If you are considering selling, you can register today for free to get started. Once registered, a Private Market Specialist will guide you through any questions you might have. You may also continue to browse through our resources to help you understand the implications and procedures involved in selling your private market shares.

Forge green plus iconForge green minus icon

What is Freeline Therapeutics's funding to date?

Freeline Therapeutics has raised $205.53MM to date.
Forge green plus iconForge green minus icon

When was Freeline Therapeutics founded?

Freeline Therapeutics was founded in 2015.
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.